Promises
3 promises
Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →
Godrej Consumer Products Limited — Q1 FY26
GCPL reported a mixed Q1 FY26.
neutral
medium
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
GCPL reported a mixed Q1 FY26. Consolidated revenue grew 10% YoY with 8% underlying volume growth, but EBITDA declined 3% YoY. India standalone delivered mid-teens volume growth excluding soaps, driven by household insecticides (high single-digit volume growth) and strong performance in air fresheners and laundry liquids. Soap volumes were impacted by grammage cuts and a poor May season. Indonesia faced macro headwinds and competitive pricing, while Africa grew sales 30% YoY. Management expects sequential margin improvement in H2 FY26, with standalone EBITDA margins below normative range in H1 but recovering in H2. Full-year guidance: mid-to-high single-digit EVG for standalone, high single-digit consolidated revenue growth, and double-digit consolidated EBITDA growth. Key risk: sustained competitive pressure in Indonesia could delay margin recovery.
GCPL ने पहली तिमाही (Q1 FY26) में मिला-जुला प्रदर्शन दिया। कंपनी की कुल आय पिछले साल की तुलना में 10% बढ़ी, जिसमें 8% वृद्धि असली बिक्री (volume growth) से आई। लेकिन मुनाफा (EBITDA) 3% घट गया। भारत में साबुन को छोड़कर बाकी उत्पादों की बिक्री में अच्छी बढ़ोतरी हुई, खासकर घरेलू कीटनाशकों, एयर फ्रेशनर और कपड़े धोने के तरल पदार्थों में। साबुन की बिक्री पर वजन कम करने और मई के खराब मौसम का असर पड़ा। इंडोनेशिया में मुश्किलें रहीं, जबकि अफ्रीका में बिक्री 30% बढ़ी। कंपनी को उम्मीद है कि दूसरी छमाही (H2) में मुनाफा बेहतर होगा। पूरे साल का अनुमान: भारत में 5-9% बिक्री वृद्धि, कुल मिलाकर 7-9% आय वृद्धि और दोहरे अंकों में मुनाफा वृद्धि। मुख्य जोखिम: इंडोनेशिया में प्रतिस्पर्धा से मुनाफा सुधार में देरी हो सकती है।
Promises0 met · 3 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Indonesia macro and competitive pressure may persist
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
India underlying volume growth (ex-soaps)
mid-teens
strong vs prior quarter
India business excluding soaps grew volumes in mid-teens, led by household insecticides and other categories.
Household insecticides volume growth
high single digits
improved from low single digits
Driven by double-digit growth in Electrics; gained market share in Electrics after relaunch.
Africa sales growth
30%
+30% YoY
Africa continued strong performance with 30% sales growth, though EBITDA grew 15% due to investments in Aer Pocket.
Indonesia pricing gap vs competitors
7-8%
corrected during quarter
GCPL was 7-8% higher than competitors on HI aerosols; corrective pricing actions taken in Q1.
What Changed vs Last Quarter
NEW
Standalone EBITDA margins below normative in H1, improving in H2
H1 FY26 standalone EBITDA margins will be below normative range, but expected to improve in H2 as palm oil benefits and cost savings kick in.
NEW
Full-year consolidated revenue growth: high single-digit
Management expects high single-digit consolidated INR revenue growth for FY26.
NEW
Full-year consolidated EBITDA growth: double-digit
Management expects double-digit consolidated EBITDA growth for FY26.
NEW
Standalone EVG: mid-to-high single digit for FY26
Underlying volume growth for standalone business expected to be mid-to-high single digit for the full year.
DROPPED
India volume and value growth sequential improvement in Q4 FY25
Management expects volume and value growth to improve sequentially in Q4 FY25, with a return to H1-like levels by Q1 FY26.
DROPPED
India EBITDA margin target of 24-26%
Management targets India EBITDA margins in the 24-26% range, expecting to reach this level in the next 6-8 months.
DROPPED
Africa organic revenue growth positive by Q4 FY25
Management expects Africa business to report positive organic revenue growth by Q4 FY25.
DROPPED
Further pricing actions in soaps
Management indicated need for one or two more rounds of pricing in soaps to restore normative margins.
NEW RISK
Indonesia macro and competitive pressure may persist
Indonesia business impacted by macro headwinds and competitive pricing; management expects transitory but uncertainty remains.
NEW RISK
Soap volume recovery may be slower than expected
Grammage cuts and poor season led to soap volume decline; recovery depends on base effects and consumer behavior.
NEW RISK
Palm oil price volatility could delay margin recovery
Palm oil prices have moderated but recently rallied 10%; benefits may be delayed if prices stay elevated.
NEW RISK
Competitive response in HI may erode market share gains
Competitors may reverse-engineer new molecule or copy messaging, potentially reducing GCPL's differentiation.
RISK GONE
Urban consumption slowdown
Management noted a significant urban slowdown, with premium products and modern trade under pressure, which could persist and impact growth.
RISK GONE
High PFAD prices delaying margin recovery
Despite palm oil correction, PFAD prices remain high, delaying margin normalization in soaps. Management expects margins to remain similar in Q4.
RISK GONE
RNF formulation adoption slower than expected
Only 40-50% of offtakes in liquid vaporizers are RNF, with old product still in pipeline. Full transition may take longer.
RISK GONE
Competitive pressure in laundry liquids
Competitors like Rin have lowered prices in liquid detergents, potentially challenging Fab's growth trajectory.
🤫 Topics management stopped discussing
Mentioned in Q2 FY25, Q3 FY25
Management targets India EBITDA margins in the 24-26% range, expecting to reach this level in the next 6-8 months.
Mentioned in Q2 FY25, Q3 FY25
Management noted a significant urban slowdown, with premium products and modern trade under pressure, which could persist and impact growth.
Fast read
Guidance and risk preview
H1 FY26 standalone EBITDA margins will be below normative range, but expected to improve in H2 as palm oil benefits and cost savings kick in.
Indonesia business impacted by macro headwinds and competitive pricing; management expects transitory but uncertainty remains.
View Risks →